Articular cartilage repair with autologous bone marrow mesenchymal cells

2010 ◽  
Vol 225 (2) ◽  
pp. 291-295 ◽  
Author(s):  
Tomiya Matsumoto ◽  
Takahiro Okabe ◽  
Tesshu Ikawa ◽  
Takahiro Iida ◽  
Hiroyuki Yasuda ◽  
...  
Cytotherapy ◽  
2013 ◽  
Vol 15 (4) ◽  
pp. S45
Author(s):  
P. Law ◽  
L. Wong ◽  
F. Wong ◽  
S. Tan ◽  
Y. Liew ◽  
...  

2019 ◽  
Vol 2019 ◽  
pp. 1-15 ◽  
Author(s):  
Mohamed E. Awad ◽  
Khaled A. Hussein ◽  
Inas Helwa ◽  
Mohamed F. Abdelsamid ◽  
Alexandra Aguilar-Perez ◽  
...  

The aim of this study is to review all the published clinical trials on autologous bone marrow mesenchymal stem cells (BM-MSCs) in the repair of cartilage lesions of the knee. We performed a comprehensive search in three electronic databases: PubMed, Medline via Ovid, and Web of Science. A systematic review was conducted according to the guidelines of PRISMA protocol and the Cochrane Handbook for Systematic Reviews of Interventions. The modified Coleman methodology score was used to assess the quality of the included studies. Meta-analysis was conducted to estimate the effect size for Pain and function change after receiving BM-MSCs. Thirty-three studies—including 724 patients of mean age 44.2 years—were eligible. 50.7% of the included patients received cultured BM-MSCs for knee cartilage repair. There was improvement in the MINORS quality score over time with a positive correlation with the publication year. Meta-analysis indicated better improvement and statistical significance in the Visual Analog Scale for Pain, IKDC Function, Tegner Activity Scale, and Lysholm Knee Score after administration of noncultured BM-MSCs when compared to evaluation before the treatment. Meanwhile, there was a clear methodological defect in most studies with an average modified Coleman methodology score (MCMS) of 55. BM-MSCs revealed a clinically relevant improvement in pain, function, and histological regeneration.


Cartilage ◽  
2014 ◽  
Vol 5 (4) ◽  
pp. 196-202 ◽  
Author(s):  
Shinya Yamasaki ◽  
Hisashi Mera ◽  
Maki Itokazu ◽  
Yusuke Hashimoto ◽  
Shigeyuki Wakitani

2015 ◽  
Vol 12 (Suppl 1) ◽  
pp. P9
Author(s):  
Ana Sergijenko ◽  
Anke J Roelofs ◽  
Andrea Augello ◽  
Cosimo De Bari

Author(s):  
O.O. Kostrub ◽  
Yu.V. Poliachenko ◽  
V.V. Kotiuk ◽  
I.A. Zasadniuk ◽  
R.I. Blonskyi ◽  
...  

Summary. Articular cartilage injuries are observed in 60% of arthroscopies. Degenerative changes of the articular cartilage (osteoarthritis) is the most common disease of all the joints, which affects at least 10-13% of the population over the age of 60 years. Significant progress has been made in the treatment of pain and inflammation, but the evidence base for improving the articular cartilage repair remains weak. Despite the seemingly positive results of a number of studies on the use of mesenchymal stem cells (MSCs) for the articular cartilage restoration, the question of the nature of their participation in this process remains controversial. Objective. The objective of the study was to determine the involvement of autologous mesenchymal bone marrow stem cells in reparative chondrogenesis. Materials and Methods. Experimental and morphological determination of the participation of undifferentiated autologous bone marrow MSCs in reparative chondrogenesis was carried out on fifteen rabbits. MSCs of bone marrow marked with a red fluorescent dye PKH-26 (Sigma, USA) was injected into the cavity of the injured joint on the 3rd day after the articular cartilage defect formation. The presence of the transplanted labeled autologous MSCs was examined in these animals on cryostat sections on the seventh, fourteenth and twenty-first days after implantation with fluorescence microscopy. The characteristic red glow was observed in case of the presence of labeled cells in the regenerated cartilage tissue. Results. The presence of transplanted labeled autologous MSCs on cryostat sections was determined in all studied animals. On the 7th day, the cells were arranged diffusely, without noticeable accumulations. On the 14th day, the labeled cells fluoresced in the red zone of the spectrum and created compact conglomerates mainly at the defect zone. On the 21th day, the labeled cells were found only in the regenerate zone. The data obtained indicate the direct participation of autologous MSCs in the processes of chondroreparation after the exogenous implantation into the joint cavity. Conclusions. The method of autologous bone marrow MSCs labeling using PKH-26 fluorescent dyes has shown that autologous bone marrow MSCs are directly involved in the processes of chondroreparation when they are injected intraarticularly.


Sign in / Sign up

Export Citation Format

Share Document